GC Biopharma Corp. (006280) Price & Analysis

― Followers

006280 Stock Chart & Stats

$114200.00

$1,000.00(0.88%)

Jul 30, 2026

―

Day’s Range― - ―

52-Week Range$108,100.00 - $183,800.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)N/A

Market Cap

₩1.29T

Enterprise Value$2.58M

Total Cash (Recent Filing)₩42.73B

Total Debt (Recent Filing)₩914.33B

Price to Earnings (P/E)―

Beta0.29

Next Earnings

Aug 05, 2026

EPS Estimate

973.79

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1217.36

Shares Outstanding11,686,538

10 Day Avg. VolumeN/A

30 Day Avg. VolumeN/A

Financial Highlights & Ratios

PEG Ratio4.72

Price to Book (P/B)1.49

Price to Sales (P/S)0.91

P/FCF Ratio66.97

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)20,211.05

Revenue Forecast (FY)₩2.00T

006280 FAQ

What was GC Biopharma Corp.’s price range in the past 12 months?

GC Biopharma Corp. lowest stock price was $108100.00 and its highest was $183800.00 in the past 12 months.

What is GC Biopharma Corp.’s market cap?

GC Biopharma Corp.’s market cap is ₩1.29T.

When is GC Biopharma Corp.’s upcoming earnings report date?

GC Biopharma Corp.’s upcoming earnings report date is Aug 05, 2026 which is in 5 days.

How were GC Biopharma Corp.’s earnings last quarter?

GC Biopharma Corp. released its earnings results on May 08, 2026. The company reported $1751.52 earnings per share for the quarter, beating the consensus estimate of -$126.2 by $1877.72.

Is GC Biopharma Corp. overvalued?

According to Wall Street analysts GC Biopharma Corp.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does GC Biopharma Corp. pay dividends?

GC Biopharma Corp. does not currently pay dividends.

What is GC Biopharma Corp.’s EPS estimate?

GC Biopharma Corp.’s EPS estimate is 973.79.

How many shares outstanding does GC Biopharma Corp. have?

GC Biopharma Corp. has 11,686,538 shares outstanding.

What happened to GC Biopharma Corp.’s price movement after its last earnings report?

GC Biopharma Corp. reported an EPS of $1751.52 in its last earnings report, beating expectations of -$126.2. Following the earnings report the stock price went up 1.098%.

Which hedge fund is a major shareholder of GC Biopharma Corp.?

Currently, no hedge funds are holding shares in KR:006280

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

GC Biopharma Corp.

GC Biopharma Corp. is a pharmaceutical enterprise primarily involved in the production and distribution of various medical products. Its extensive portfolio encompasses specialized treatments for blood-related conditions, non-prescription remedies, general medications, and immunizations, among other therapeutic solutions. The company was established on November 1, 1969, and its principal corporate offices are situated in Yongin, South Korea.